|
ZNF558 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.21329995734266E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.8318000024401E-08 |
| Normal-vs-Stage2 |
4.801100000007E-06 |
| Normal-vs-Stage3 |
1.23379999994455E-07 |
| Normal-vs-Stage4 |
2.19549999999069E-05 |
| Stage1-vs-Stage2 |
6.529000E-01 |
| Stage1-vs-Stage3 |
2.222400E-01 |
| Stage1-vs-Stage4 |
3.398200E-01 |
| Stage2-vs-Stage3 |
6.696800E-01 |
| Stage2-vs-Stage4 |
6.109400E-01 |
| Stage3-vs-Stage4 |
8.544000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.35580005187353E-09 |
| Normal-vs-AfricanAmerican |
7.382800E-04 |
| Normal-vs-Asian |
1.619430E-04 |
| Caucasian-vs-AfricanAmerican |
9.480200E-01 |
| Caucasian-vs-Asian |
3.514600E-01 |
| AfricanAmerican-vs-Asian |
5.644400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.90129999999566E-06 |
| Normal-vs-Female |
6.19160001047447E-09 |
| Male-vs-Female |
5.729400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.77619999608814E-08 |
| Normal-vs-Age(41-60Yrs) |
1.55139999735709E-08 |
| Normal-vs-Age(61-80Yrs) |
5.59289999999546E-05 |
| Normal-vs-Age(81-100Yrs) |
6.019400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.966800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.622800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.313600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.703400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.137400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.931200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.57160000000745E-05 |
| Classical-VS-Follicular |
9.339600E-01 |
| Classical-VS-Other |
9.172400E-01 |
| Classical-VS-Normal |
1.44379999955646E-07 |
| Tall-VS-Follicular |
1.075310E-03 |
| Tall-VS-Other |
2.962800E-01 |
| Tall-VS-Normal |
6.67920163621716E-11 |
| Follicular-VS-Other |
8.733400E-01 |
| Follicular-VS-Normal |
1.420700E-04 |
| Other-VS-Normal |
1.083040E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.96830000035398E-07 |
| Normal-vs-N1 |
8.194200E-04 |
| N0-vs-N1 |
7.953400E-01 |
|
|
